nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—ABCB1—ovarian cancer	0.201	1	CbGaD
Amitriptyline—ABCB1—Topotecan—ovarian cancer	0.0323	0.118	CbGbCtD
Amitriptyline—CYP3A5—Paclitaxel—ovarian cancer	0.0246	0.0895	CbGbCtD
Amitriptyline—CYP2C8—Paclitaxel—ovarian cancer	0.0236	0.086	CbGbCtD
Amitriptyline—ABCB1—Vinorelbine—ovarian cancer	0.0228	0.0829	CbGbCtD
Amitriptyline—CYP2D6—Vinorelbine—ovarian cancer	0.0215	0.0781	CbGbCtD
Amitriptyline—CYP3A4—Topotecan—ovarian cancer	0.0194	0.0705	CbGbCtD
Amitriptyline—CYP3A5—Docetaxel—ovarian cancer	0.0178	0.0647	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—ovarian cancer	0.0168	0.0612	CbGbCtD
Amitriptyline—CYP2C9—Paclitaxel—ovarian cancer	0.0165	0.06	CbGbCtD
Amitriptyline—ABCB1—Paclitaxel—ovarian cancer	0.016	0.0582	CbGbCtD
Amitriptyline—CYP3A4—Vinorelbine—ovarian cancer	0.0136	0.0496	CbGbCtD
Amitriptyline—ABCB1—Docetaxel—ovarian cancer	0.0116	0.0421	CbGbCtD
Amitriptyline—CYP3A4—Paclitaxel—ovarian cancer	0.00959	0.0349	CbGbCtD
Amitriptyline—ABCB1—Doxorubicin—ovarian cancer	0.00863	0.0314	CbGbCtD
Amitriptyline—CHRM3—muscle of abdomen—ovarian cancer	0.00839	0.0599	CbGeAlD
Amitriptyline—CYP2D6—Doxorubicin—ovarian cancer	0.00813	0.0296	CbGbCtD
Amitriptyline—CYP3A4—Docetaxel—ovarian cancer	0.00693	0.0252	CbGbCtD
Amitriptyline—HTR7—vein—ovarian cancer	0.00616	0.044	CbGeAlD
Amitriptyline—CYP3A4—Doxorubicin—ovarian cancer	0.00517	0.0188	CbGbCtD
Amitriptyline—NTRK1—decidua—ovarian cancer	0.00514	0.0367	CbGeAlD
Amitriptyline—HTR2A—vein—ovarian cancer	0.00384	0.0274	CbGeAlD
Amitriptyline—KCND2—myometrium—ovarian cancer	0.00351	0.025	CbGeAlD
Amitriptyline—NTRK2—gonad—ovarian cancer	0.00347	0.0247	CbGeAlD
Amitriptyline—NTRK1—testis—ovarian cancer	0.00326	0.0233	CbGeAlD
Amitriptyline—HRH4—bone marrow—ovarian cancer	0.00312	0.0223	CbGeAlD
Amitriptyline—NTRK2—female reproductive system—ovarian cancer	0.0031	0.0221	CbGeAlD
Amitriptyline—NTRK2—bone marrow—ovarian cancer	0.00292	0.0209	CbGeAlD
Amitriptyline—NTRK2—female gonad—ovarian cancer	0.00282	0.0201	CbGeAlD
Amitriptyline—KCND2—decidua—ovarian cancer	0.0026	0.0186	CbGeAlD
Amitriptyline—NTRK2—testis—ovarian cancer	0.0025	0.0178	CbGeAlD
Amitriptyline—KCNQ2—gonad—ovarian cancer	0.00242	0.0173	CbGeAlD
Amitriptyline—KCND3—uterine cervix—ovarian cancer	0.00238	0.017	CbGeAlD
Amitriptyline—KCNQ3—female reproductive system—ovarian cancer	0.00235	0.0168	CbGeAlD
Amitriptyline—KCNQ2—female reproductive system—ovarian cancer	0.00216	0.0154	CbGeAlD
Amitriptyline—KCND3—uterus—ovarian cancer	0.00198	0.0142	CbGeAlD
Amitriptyline—KCNQ2—female gonad—ovarian cancer	0.00196	0.014	CbGeAlD
Amitriptyline—KCND2—female gonad—ovarian cancer	0.00186	0.0133	CbGeAlD
Amitriptyline—NTRK2—lymph node—ovarian cancer	0.00181	0.0129	CbGeAlD
Amitriptyline—CHRM5—epithelium—ovarian cancer	0.00179	0.0128	CbGeAlD
Amitriptyline—KCNQ2—testis—ovarian cancer	0.00174	0.0124	CbGeAlD
Amitriptyline—KCND2—testis—ovarian cancer	0.00165	0.0118	CbGeAlD
Amitriptyline—ADRA1D—epithelium—ovarian cancer	0.0016	0.0114	CbGeAlD
Amitriptyline—KCND3—testis—ovarian cancer	0.00144	0.0103	CbGeAlD
Amitriptyline—SIGMAR1—myometrium—ovarian cancer	0.00142	0.0101	CbGeAlD
Amitriptyline—OPRK1—female reproductive system—ovarian cancer	0.00141	0.01	CbGeAlD
Amitriptyline—CHRM4—testis—ovarian cancer	0.00137	0.00979	CbGeAlD
Amitriptyline—ADRA1D—female reproductive system—ovarian cancer	0.00119	0.00847	CbGeAlD
Amitriptyline—ORM1—endometrium—ovarian cancer	0.00118	0.00842	CbGeAlD
Amitriptyline—SIGMAR1—uterine cervix—ovarian cancer	0.0011	0.00788	CbGeAlD
Amitriptyline—SIGMAR1—decidua—ovarian cancer	0.00105	0.00751	CbGeAlD
Amitriptyline—KCND3—lymph node—ovarian cancer	0.00104	0.00745	CbGeAlD
Amitriptyline—SIGMAR1—endometrium—ovarian cancer	0.000998	0.00713	CbGeAlD
Amitriptyline—ORM1—female reproductive system—ovarian cancer	0.000977	0.00698	CbGeAlD
Amitriptyline—HTR7—epithelium—ovarian cancer	0.000951	0.00679	CbGeAlD
Amitriptyline—SLC6A2—decidua—ovarian cancer	0.000932	0.00665	CbGeAlD
Amitriptyline—ORM1—bone marrow—ovarian cancer	0.000922	0.00659	CbGeAlD
Amitriptyline—SIGMAR1—uterus—ovarian cancer	0.00092	0.00657	CbGeAlD
Amitriptyline—ADRA1A—epithelium—ovarian cancer	0.000917	0.00655	CbGeAlD
Amitriptyline—HTR1B—female reproductive system—ovarian cancer	0.000916	0.00654	CbGeAlD
Amitriptyline—HRH1—myometrium—ovarian cancer	0.000905	0.00646	CbGeAlD
Amitriptyline—ADRA2A—myometrium—ovarian cancer	0.000889	0.00634	CbGeAlD
Amitriptyline—HTR1D—female reproductive system—ovarian cancer	0.000887	0.00633	CbGeAlD
Amitriptyline—HTR2C—female reproductive system—ovarian cancer	0.000878	0.00627	CbGeAlD
Amitriptyline—SLC6A4—female reproductive system—ovarian cancer	0.000833	0.00594	CbGeAlD
Amitriptyline—CHRM1—female reproductive system—ovarian cancer	0.000829	0.00592	CbGeAlD
Amitriptyline—SLC6A2—gonad—ovarian cancer	0.000821	0.00586	CbGeAlD
Amitriptyline—HRH2—lymph node—ovarian cancer	0.000813	0.0058	CbGeAlD
Amitriptyline—OPRM1—testis—ovarian cancer	0.000808	0.00577	CbGeAlD
Amitriptyline—HTR7—gonad—ovarian cancer	0.000791	0.00565	CbGeAlD
Amitriptyline—SIGMAR1—bone marrow—ovarian cancer	0.000781	0.00557	CbGeAlD
Amitriptyline—SIGMAR1—female gonad—ovarian cancer	0.000752	0.00537	CbGeAlD
Amitriptyline—SIGMAR1—vagina—ovarian cancer	0.000748	0.00534	CbGeAlD
Amitriptyline—CHRM3—female reproductive system—ovarian cancer	0.000742	0.0053	CbGeAlD
Amitriptyline—SLC6A2—female reproductive system—ovarian cancer	0.000733	0.00523	CbGeAlD
Amitriptyline—CYP2C8—endometrium—ovarian cancer	0.000727	0.00519	CbGeAlD
Amitriptyline—HTR2A—embryo—ovarian cancer	0.000727	0.00519	CbGeAlD
Amitriptyline—CYP3A5—uterine cervix—ovarian cancer	0.000725	0.00518	CbGeAlD
Amitriptyline—HRH1—epithelium—ovarian cancer	0.00071	0.00507	CbGeAlD
Amitriptyline—HTR7—female reproductive system—ovarian cancer	0.000706	0.00504	CbGeAlD
Amitriptyline—HRH1—uterine cervix—ovarian cancer	0.000704	0.00503	CbGeAlD
Amitriptyline—ADRA2A—uterine cervix—ovarian cancer	0.000691	0.00494	CbGeAlD
Amitriptyline—ALB—testis—ovarian cancer	0.000691	0.00494	CbGeAlD
Amitriptyline—CHRM3—female gonad—ovarian cancer	0.000675	0.00482	CbGeAlD
Amitriptyline—HRH1—decidua—ovarian cancer	0.000671	0.00479	CbGeAlD
Amitriptyline—SIGMAR1—testis—ovarian cancer	0.000667	0.00476	CbGeAlD
Amitriptyline—ADRA2A—decidua—ovarian cancer	0.000659	0.0047	CbGeAlD
Amitriptyline—HRH1—endometrium—ovarian cancer	0.000637	0.00455	CbGeAlD
Amitriptyline—ADRA2A—endometrium—ovarian cancer	0.000625	0.00447	CbGeAlD
Amitriptyline—CYP2C19—vagina—ovarian cancer	0.000624	0.00445	CbGeAlD
Amitriptyline—CYP2B6—gonad—ovarian cancer	0.000605	0.00432	CbGeAlD
Amitriptyline—CYP2C8—female reproductive system—ovarian cancer	0.000602	0.0043	CbGeAlD
Amitriptyline—CHRM3—testis—ovarian cancer	0.000599	0.00428	CbGeAlD
Amitriptyline—HTR2A—epithelium—ovarian cancer	0.000593	0.00423	CbGeAlD
Amitriptyline—SLC6A2—testis—ovarian cancer	0.000592	0.00422	CbGeAlD
Amitriptyline—ADRA2A—gonad—ovarian cancer	0.00058	0.00414	CbGeAlD
Amitriptyline—ADRA2A—uterus—ovarian cancer	0.000576	0.00411	CbGeAlD
Amitriptyline—ORM1—lymph node—ovarian cancer	0.000572	0.00408	CbGeAlD
Amitriptyline—HTR7—testis—ovarian cancer	0.00057	0.00407	CbGeAlD
Amitriptyline—CYP2C8—vagina—ovarian cancer	0.000545	0.00389	CbGeAlD
Amitriptyline—CYP2B6—female reproductive system—ovarian cancer	0.00054	0.00386	CbGeAlD
Amitriptyline—DRD2—testis—ovarian cancer	0.000539	0.00385	CbGeAlD
Amitriptyline—CYP2C9—female reproductive system—ovarian cancer	0.000535	0.00382	CbGeAlD
Amitriptyline—HRH1—female reproductive system—ovarian cancer	0.000527	0.00377	CbGeAlD
Amitriptyline—ADRA2A—female reproductive system—ovarian cancer	0.000518	0.0037	CbGeAlD
Amitriptyline—CYP2E1—female reproductive system—ovarian cancer	0.000507	0.00362	CbGeAlD
Amitriptyline—ALB—lymph node—ovarian cancer	0.000501	0.00358	CbGeAlD
Amitriptyline—ABCB1—myometrium—ovarian cancer	0.000495	0.00354	CbGeAlD
Amitriptyline—CYP3A5—female gonad—ovarian cancer	0.000494	0.00353	CbGeAlD
Amitriptyline—HTR2A—gonad—ovarian cancer	0.000493	0.00352	CbGeAlD
Amitriptyline—CYP3A5—vagina—ovarian cancer	0.000491	0.00351	CbGeAlD
Amitriptyline—CYP2B6—vagina—ovarian cancer	0.000488	0.00349	CbGeAlD
Amitriptyline—CYP2C8—testis—ovarian cancer	0.000486	0.00347	CbGeAlD
Amitriptyline—SIGMAR1—lymph node—ovarian cancer	0.000484	0.00345	CbGeAlD
Amitriptyline—HRH1—female gonad—ovarian cancer	0.00048	0.00343	CbGeAlD
Amitriptyline—HRH1—vagina—ovarian cancer	0.000477	0.00341	CbGeAlD
Amitriptyline—ABCB1—embryo—ovarian cancer	0.000476	0.0034	CbGeAlD
Amitriptyline—Coma—Doxorubicin—ovarian cancer	0.000472	0.00221	CcSEcCtD
Amitriptyline—ADRA2A—female gonad—ovarian cancer	0.000471	0.00337	CbGeAlD
Amitriptyline—Urticaria—Melphalan—ovarian cancer	0.000471	0.0022	CcSEcCtD
Amitriptyline—ADRA2A—vagina—ovarian cancer	0.000469	0.00335	CbGeAlD
Amitriptyline—Diarrhoea—Chlorambucil—ovarian cancer	0.000465	0.00218	CcSEcCtD
Amitriptyline—Paraesthesia—Vinorelbine—ovarian cancer	0.000465	0.00218	CcSEcCtD
Amitriptyline—Tinnitus—Paclitaxel—ovarian cancer	0.000457	0.00214	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000456	0.00213	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000454	0.00212	CcSEcCtD
Amitriptyline—Myocardial infarction—Docetaxel—ovarian cancer	0.000454	0.00212	CcSEcCtD
Amitriptyline—Vascular purpura—Epirubicin—ovarian cancer	0.000453	0.00212	CcSEcCtD
Amitriptyline—Jaundice—Docetaxel—ovarian cancer	0.000451	0.00211	CcSEcCtD
Amitriptyline—Stomatitis—Docetaxel—ovarian cancer	0.000451	0.00211	CcSEcCtD
Amitriptyline—Hepatic failure—Epirubicin—ovarian cancer	0.000451	0.00211	CcSEcCtD
Amitriptyline—Decreased appetite—Vinorelbine—ovarian cancer	0.00045	0.00211	CcSEcCtD
Amitriptyline—Mental disability—Doxorubicin—ovarian cancer	0.000448	0.0021	CcSEcCtD
Amitriptyline—Fatigue—Vinorelbine—ovarian cancer	0.000446	0.00209	CcSEcCtD
Amitriptyline—Constipation—Vinorelbine—ovarian cancer	0.000443	0.00207	CcSEcCtD
Amitriptyline—HTR2A—female reproductive system—ovarian cancer	0.000441	0.00315	CbGeAlD
Amitriptyline—Arrhythmia—Paclitaxel—ovarian cancer	0.000438	0.00205	CcSEcCtD
Amitriptyline—CYP2B6—testis—ovarian cancer	0.000436	0.00311	CbGeAlD
Amitriptyline—Asthenia—Topotecan—ovarian cancer	0.000434	0.00203	CcSEcCtD
Amitriptyline—Alopecia—Paclitaxel—ovarian cancer	0.000433	0.00203	CcSEcCtD
Amitriptyline—Vomiting—Chlorambucil—ovarian cancer	0.000432	0.00202	CcSEcCtD
Amitriptyline—Agranulocytosis—Docetaxel—ovarian cancer	0.000432	0.00202	CcSEcCtD
Amitriptyline—SLC6A2—lymph node—ovarian cancer	0.000429	0.00306	CbGeAlD
Amitriptyline—Pruritus—Topotecan—ovarian cancer	0.000428	0.002	CcSEcCtD
Amitriptyline—Feeling abnormal—Vinorelbine—ovarian cancer	0.000427	0.002	CcSEcCtD
Amitriptyline—HRH1—testis—ovarian cancer	0.000426	0.00304	CbGeAlD
Amitriptyline—Asthenia—Melphalan—ovarian cancer	0.000425	0.00199	CcSEcCtD
Amitriptyline—Purpura—Epirubicin—ovarian cancer	0.00042	0.00197	CcSEcCtD
Amitriptyline—Pruritus—Melphalan—ovarian cancer	0.000419	0.00196	CcSEcCtD
Amitriptyline—Vascular purpura—Doxorubicin—ovarian cancer	0.000419	0.00196	CcSEcCtD
Amitriptyline—ADRA2A—testis—ovarian cancer	0.000418	0.00299	CbGeAlD
Amitriptyline—Dysgeusia—Paclitaxel—ovarian cancer	0.000418	0.00196	CcSEcCtD
Amitriptyline—Hepatic failure—Doxorubicin—ovarian cancer	0.000417	0.00195	CcSEcCtD
Amitriptyline—Hepatitis—Docetaxel—ovarian cancer	0.000415	0.00194	CcSEcCtD
Amitriptyline—Diarrhoea—Topotecan—ovarian cancer	0.000414	0.00194	CcSEcCtD
Amitriptyline—Hypoaesthesia—Docetaxel—ovarian cancer	0.000413	0.00193	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000413	0.00193	CcSEcCtD
Amitriptyline—Urticaria—Vinorelbine—ovarian cancer	0.000411	0.00192	CcSEcCtD
Amitriptyline—Body temperature increased—Vinorelbine—ovarian cancer	0.000409	0.00191	CcSEcCtD
Amitriptyline—CYP2E1—testis—ovarian cancer	0.000409	0.00292	CbGeAlD
Amitriptyline—CYP3A4—female reproductive system—ovarian cancer	0.000408	0.00291	CbGeAlD
Amitriptyline—Diarrhoea—Melphalan—ovarian cancer	0.000405	0.0019	CcSEcCtD
Amitriptyline—Osteoarthritis—Epirubicin—ovarian cancer	0.000405	0.0019	CcSEcCtD
Amitriptyline—Nausea—Chlorambucil—ovarian cancer	0.000404	0.00189	CcSEcCtD
Amitriptyline—Vision blurred—Paclitaxel—ovarian cancer	0.000402	0.00188	CcSEcCtD
Amitriptyline—CYP2D6—female reproductive system—ovarian cancer	0.000401	0.00287	CbGeAlD
Amitriptyline—Dizziness—Topotecan—ovarian cancer	0.0004	0.00187	CcSEcCtD
Amitriptyline—Tremor—Paclitaxel—ovarian cancer	0.0004	0.00187	CcSEcCtD
Amitriptyline—HTR2A—vagina—ovarian cancer	0.000398	0.00284	CbGeAlD
Amitriptyline—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000396	0.00185	CcSEcCtD
Amitriptyline—Agitation—Paclitaxel—ovarian cancer	0.000392	0.00183	CcSEcCtD
Amitriptyline—Purpura—Doxorubicin—ovarian cancer	0.000389	0.00182	CcSEcCtD
Amitriptyline—ABCB1—epithelium—ovarian cancer	0.000389	0.00277	CbGeAlD
Amitriptyline—ABCB1—uterine cervix—ovarian cancer	0.000385	0.00275	CbGeAlD
Amitriptyline—Vomiting—Topotecan—ovarian cancer	0.000385	0.0018	CcSEcCtD
Amitriptyline—Malaise—Paclitaxel—ovarian cancer	0.000385	0.0018	CcSEcCtD
Amitriptyline—Syncope—Paclitaxel—ovarian cancer	0.000383	0.00179	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000382	0.00179	CcSEcCtD
Amitriptyline—Leukopenia—Paclitaxel—ovarian cancer	0.000382	0.00179	CcSEcCtD
Amitriptyline—Rash—Topotecan—ovarian cancer	0.000382	0.00179	CcSEcCtD
Amitriptyline—Dermatitis—Topotecan—ovarian cancer	0.000381	0.00178	CcSEcCtD
Amitriptyline—Ataxia—Epirubicin—ovarian cancer	0.000381	0.00178	CcSEcCtD
Amitriptyline—Headache—Topotecan—ovarian cancer	0.000379	0.00177	CcSEcCtD
Amitriptyline—Palpitations—Paclitaxel—ovarian cancer	0.000377	0.00176	CcSEcCtD
Amitriptyline—Vomiting—Melphalan—ovarian cancer	0.000377	0.00176	CcSEcCtD
Amitriptyline—Loss of consciousness—Paclitaxel—ovarian cancer	0.000375	0.00175	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—ovarian cancer	0.000375	0.00175	CcSEcCtD
Amitriptyline—Rash—Melphalan—ovarian cancer	0.000374	0.00175	CcSEcCtD
Amitriptyline—Dermatitis—Melphalan—ovarian cancer	0.000373	0.00175	CcSEcCtD
Amitriptyline—Asthenia—Vinorelbine—ovarian cancer	0.000371	0.00174	CcSEcCtD
Amitriptyline—Arrhythmia—Docetaxel—ovarian cancer	0.000371	0.00174	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00037	0.00173	CcSEcCtD
Amitriptyline—Convulsion—Paclitaxel—ovarian cancer	0.00037	0.00173	CcSEcCtD
Amitriptyline—Hypertension—Paclitaxel—ovarian cancer	0.000368	0.00172	CcSEcCtD
Amitriptyline—Alopecia—Docetaxel—ovarian cancer	0.000367	0.00172	CcSEcCtD
Amitriptyline—ABCB1—decidua—ovarian cancer	0.000367	0.00262	CbGeAlD
Amitriptyline—Pruritus—Vinorelbine—ovarian cancer	0.000366	0.00171	CcSEcCtD
Amitriptyline—CYP2D6—female gonad—ovarian cancer	0.000365	0.00261	CbGeAlD
Amitriptyline—Anxiety—Paclitaxel—ovarian cancer	0.000362	0.00169	CcSEcCtD
Amitriptyline—Nausea—Topotecan—ovarian cancer	0.00036	0.00168	CcSEcCtD
Amitriptyline—Discomfort—Paclitaxel—ovarian cancer	0.000359	0.00168	CcSEcCtD
Amitriptyline—HTR2A—testis—ovarian cancer	0.000356	0.00254	CbGeAlD
Amitriptyline—Dry mouth—Paclitaxel—ovarian cancer	0.000355	0.00166	CcSEcCtD
Amitriptyline—Diarrhoea—Vinorelbine—ovarian cancer	0.000354	0.00166	CcSEcCtD
Amitriptyline—Dysgeusia—Docetaxel—ovarian cancer	0.000354	0.00166	CcSEcCtD
Amitriptyline—Ataxia—Doxorubicin—ovarian cancer	0.000352	0.00165	CcSEcCtD
Amitriptyline—Nausea—Melphalan—ovarian cancer	0.000352	0.00165	CcSEcCtD
Amitriptyline—Confusional state—Paclitaxel—ovarian cancer	0.000351	0.00164	CcSEcCtD
Amitriptyline—ABCB1—endometrium—ovarian cancer	0.000348	0.00249	CbGeAlD
Amitriptyline—Oedema—Paclitaxel—ovarian cancer	0.000348	0.00163	CcSEcCtD
Amitriptyline—Eosinophilia—Epirubicin—ovarian cancer	0.000347	0.00162	CcSEcCtD
Amitriptyline—Shock—Paclitaxel—ovarian cancer	0.000343	0.0016	CcSEcCtD
Amitriptyline—Dizziness—Vinorelbine—ovarian cancer	0.000342	0.0016	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000342	0.0016	CcSEcCtD
Amitriptyline—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000341	0.0016	CcSEcCtD
Amitriptyline—Tachycardia—Paclitaxel—ovarian cancer	0.00034	0.00159	CcSEcCtD
Amitriptyline—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000337	0.00158	CcSEcCtD
Amitriptyline—Pancytopenia—Epirubicin—ovarian cancer	0.000332	0.00156	CcSEcCtD
Amitriptyline—Anorexia—Paclitaxel—ovarian cancer	0.000332	0.00155	CcSEcCtD
Amitriptyline—Vomiting—Vinorelbine—ovarian cancer	0.000329	0.00154	CcSEcCtD
Amitriptyline—Rash—Vinorelbine—ovarian cancer	0.000326	0.00153	CcSEcCtD
Amitriptyline—Dermatitis—Vinorelbine—ovarian cancer	0.000326	0.00153	CcSEcCtD
Amitriptyline—Hypotension—Paclitaxel—ovarian cancer	0.000325	0.00152	CcSEcCtD
Amitriptyline—Headache—Vinorelbine—ovarian cancer	0.000324	0.00152	CcSEcCtD
Amitriptyline—Syncope—Docetaxel—ovarian cancer	0.000324	0.00152	CcSEcCtD
Amitriptyline—CYP2D6—testis—ovarian cancer	0.000324	0.00231	CbGeAlD
Amitriptyline—Leukopenia—Docetaxel—ovarian cancer	0.000324	0.00151	CcSEcCtD
Amitriptyline—Pollakiuria—Epirubicin—ovarian cancer	0.000323	0.00151	CcSEcCtD
Amitriptyline—ABCB1—gonad—ovarian cancer	0.000323	0.00231	CbGeAlD
Amitriptyline—ABCB1—uterus—ovarian cancer	0.000321	0.00229	CbGeAlD
Amitriptyline—Eosinophilia—Doxorubicin—ovarian cancer	0.000321	0.0015	CcSEcCtD
Amitriptyline—Palpitations—Docetaxel—ovarian cancer	0.00032	0.0015	CcSEcCtD
Amitriptyline—Weight increased—Epirubicin—ovarian cancer	0.000319	0.00149	CcSEcCtD
Amitriptyline—Loss of consciousness—Docetaxel—ovarian cancer	0.000318	0.00149	CcSEcCtD
Amitriptyline—Insomnia—Paclitaxel—ovarian cancer	0.000315	0.00147	CcSEcCtD
Amitriptyline—Convulsion—Docetaxel—ovarian cancer	0.000313	0.00147	CcSEcCtD
Amitriptyline—Paraesthesia—Paclitaxel—ovarian cancer	0.000313	0.00146	CcSEcCtD
Amitriptyline—Hypertension—Docetaxel—ovarian cancer	0.000312	0.00146	CcSEcCtD
Amitriptyline—Drowsiness—Epirubicin—ovarian cancer	0.000312	0.00146	CcSEcCtD
Amitriptyline—Somnolence—Paclitaxel—ovarian cancer	0.00031	0.00145	CcSEcCtD
Amitriptyline—HRH1—lymph node—ovarian cancer	0.000309	0.0022	CbGeAlD
Amitriptyline—Pancytopenia—Doxorubicin—ovarian cancer	0.000308	0.00144	CcSEcCtD
Amitriptyline—Nausea—Vinorelbine—ovarian cancer	0.000308	0.00144	CcSEcCtD
Amitriptyline—Dyspepsia—Paclitaxel—ovarian cancer	0.000307	0.00143	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000306	0.00143	CcSEcCtD
Amitriptyline—Jaundice—Epirubicin—ovarian cancer	0.000304	0.00142	CcSEcCtD
Amitriptyline—Stomatitis—Epirubicin—ovarian cancer	0.000304	0.00142	CcSEcCtD
Amitriptyline—ADRA2A—lymph node—ovarian cancer	0.000303	0.00216	CbGeAlD
Amitriptyline—Decreased appetite—Paclitaxel—ovarian cancer	0.000303	0.00142	CcSEcCtD
Amitriptyline—Dry mouth—Docetaxel—ovarian cancer	0.000301	0.00141	CcSEcCtD
Amitriptyline—Fatigue—Paclitaxel—ovarian cancer	0.0003	0.0014	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—ovarian cancer	0.000299	0.0014	CcSEcCtD
Amitriptyline—Constipation—Paclitaxel—ovarian cancer	0.000298	0.00139	CcSEcCtD
Amitriptyline—Confusional state—Docetaxel—ovarian cancer	0.000298	0.00139	CcSEcCtD
Amitriptyline—Oedema—Docetaxel—ovarian cancer	0.000295	0.00138	CcSEcCtD
Amitriptyline—Weight increased—Doxorubicin—ovarian cancer	0.000295	0.00138	CcSEcCtD
Amitriptyline—Agranulocytosis—Epirubicin—ovarian cancer	0.000291	0.00136	CcSEcCtD
Amitriptyline—Shock—Docetaxel—ovarian cancer	0.00029	0.00136	CcSEcCtD
Amitriptyline—Thrombocytopenia—Docetaxel—ovarian cancer	0.000289	0.00135	CcSEcCtD
Amitriptyline—Drowsiness—Doxorubicin—ovarian cancer	0.000289	0.00135	CcSEcCtD
Amitriptyline—ABCB1—female reproductive system—ovarian cancer	0.000289	0.00206	CbGeAlD
Amitriptyline—Tachycardia—Docetaxel—ovarian cancer	0.000288	0.00135	CcSEcCtD
Amitriptyline—Feeling abnormal—Paclitaxel—ovarian cancer	0.000287	0.00134	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000283	0.00132	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—ovarian cancer	0.000282	0.00132	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—ovarian cancer	0.000282	0.00132	CcSEcCtD
Amitriptyline—Anorexia—Docetaxel—ovarian cancer	0.000281	0.00132	CcSEcCtD
Amitriptyline—Hepatitis—Epirubicin—ovarian cancer	0.00028	0.00131	CcSEcCtD
Amitriptyline—Hypoaesthesia—Epirubicin—ovarian cancer	0.000279	0.0013	CcSEcCtD
Amitriptyline—Urticaria—Paclitaxel—ovarian cancer	0.000277	0.00129	CcSEcCtD
Amitriptyline—Hypotension—Docetaxel—ovarian cancer	0.000276	0.00129	CcSEcCtD
Amitriptyline—Body temperature increased—Paclitaxel—ovarian cancer	0.000275	0.00129	CcSEcCtD
Amitriptyline—ABCB1—bone marrow—ovarian cancer	0.000273	0.00195	CbGeAlD
Amitriptyline—Agranulocytosis—Doxorubicin—ovarian cancer	0.00027	0.00126	CcSEcCtD
Amitriptyline—Insomnia—Docetaxel—ovarian cancer	0.000267	0.00125	CcSEcCtD
Amitriptyline—Paraesthesia—Docetaxel—ovarian cancer	0.000265	0.00124	CcSEcCtD
Amitriptyline—ABCB1—female gonad—ovarian cancer	0.000263	0.00188	CbGeAlD
Amitriptyline—Somnolence—Docetaxel—ovarian cancer	0.000262	0.00123	CcSEcCtD
Amitriptyline—Tinnitus—Epirubicin—ovarian cancer	0.000261	0.00122	CcSEcCtD
Amitriptyline—ABCB1—vagina—ovarian cancer	0.000261	0.00186	CbGeAlD
Amitriptyline—Dyspepsia—Docetaxel—ovarian cancer	0.00026	0.00122	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—ovarian cancer	0.000259	0.00121	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000258	0.00121	CcSEcCtD
Amitriptyline—Decreased appetite—Docetaxel—ovarian cancer	0.000257	0.0012	CcSEcCtD
Amitriptyline—Fatigue—Docetaxel—ovarian cancer	0.000254	0.00119	CcSEcCtD
Amitriptyline—Constipation—Docetaxel—ovarian cancer	0.000252	0.00118	CcSEcCtD
Amitriptyline—Arrhythmia—Epirubicin—ovarian cancer	0.00025	0.00117	CcSEcCtD
Amitriptyline—Asthenia—Paclitaxel—ovarian cancer	0.00025	0.00117	CcSEcCtD
Amitriptyline—Alopecia—Epirubicin—ovarian cancer	0.000248	0.00116	CcSEcCtD
Amitriptyline—Pruritus—Paclitaxel—ovarian cancer	0.000246	0.00115	CcSEcCtD
Amitriptyline—Feeling abnormal—Docetaxel—ovarian cancer	0.000243	0.00114	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—ovarian cancer	0.000242	0.00113	CcSEcCtD
Amitriptyline—Dysgeusia—Epirubicin—ovarian cancer	0.000239	0.00112	CcSEcCtD
Amitriptyline—Diarrhoea—Paclitaxel—ovarian cancer	0.000238	0.00111	CcSEcCtD
Amitriptyline—Body temperature increased—Docetaxel—ovarian cancer	0.000233	0.00109	CcSEcCtD
Amitriptyline—ABCB1—testis—ovarian cancer	0.000233	0.00166	CbGeAlD
Amitriptyline—Arrhythmia—Doxorubicin—ovarian cancer	0.000232	0.00108	CcSEcCtD
Amitriptyline—Dizziness—Paclitaxel—ovarian cancer	0.00023	0.00108	CcSEcCtD
Amitriptyline—Vision blurred—Epirubicin—ovarian cancer	0.00023	0.00108	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—ovarian cancer	0.000229	0.00107	CcSEcCtD
Amitriptyline—Ill-defined disorder—Epirubicin—ovarian cancer	0.000226	0.00106	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—ovarian cancer	0.000224	0.00105	CcSEcCtD
Amitriptyline—Vomiting—Paclitaxel—ovarian cancer	0.000221	0.00104	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—ovarian cancer	0.000221	0.00103	CcSEcCtD
Amitriptyline—Malaise—Epirubicin—ovarian cancer	0.00022	0.00103	CcSEcCtD
Amitriptyline—Rash—Paclitaxel—ovarian cancer	0.00022	0.00103	CcSEcCtD
Amitriptyline—Dermatitis—Paclitaxel—ovarian cancer	0.000219	0.00103	CcSEcCtD
Amitriptyline—Syncope—Epirubicin—ovarian cancer	0.000219	0.00102	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—ovarian cancer	0.000218	0.00102	CcSEcCtD
Amitriptyline—Headache—Paclitaxel—ovarian cancer	0.000218	0.00102	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—ovarian cancer	0.000216	0.00101	CcSEcCtD
Amitriptyline—Loss of consciousness—Epirubicin—ovarian cancer	0.000214	0.001	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—ovarian cancer	0.000213	0.000995	CcSEcCtD
Amitriptyline—Asthenia—Docetaxel—ovarian cancer	0.000212	0.000991	CcSEcCtD
Amitriptyline—Convulsion—Epirubicin—ovarian cancer	0.000211	0.000989	CcSEcCtD
Amitriptyline—Hypertension—Epirubicin—ovarian cancer	0.000211	0.000985	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000209	0.00098	CcSEcCtD
Amitriptyline—Pruritus—Docetaxel—ovarian cancer	0.000209	0.000977	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—ovarian cancer	0.000207	0.00097	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—ovarian cancer	0.000207	0.000968	CcSEcCtD
Amitriptyline—Nausea—Paclitaxel—ovarian cancer	0.000207	0.000968	CcSEcCtD
Amitriptyline—Discomfort—Epirubicin—ovarian cancer	0.000205	0.00096	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—ovarian cancer	0.000204	0.000952	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—ovarian cancer	0.000203	0.00095	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—ovarian cancer	0.000202	0.000947	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—ovarian cancer	0.000202	0.000945	CcSEcCtD
Amitriptyline—Diarrhoea—Docetaxel—ovarian cancer	0.000202	0.000945	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—ovarian cancer	0.000201	0.000939	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—ovarian cancer	0.000199	0.000933	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—ovarian cancer	0.000199	0.000932	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—ovarian cancer	0.000198	0.000928	CcSEcCtD
Amitriptyline—Shock—Epirubicin—ovarian cancer	0.000196	0.000916	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—ovarian cancer	0.000196	0.000915	CcSEcCtD
Amitriptyline—Dizziness—Docetaxel—ovarian cancer	0.000195	0.000913	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—ovarian cancer	0.000195	0.000912	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—ovarian cancer	0.000195	0.000912	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—ovarian cancer	0.000194	0.000909	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—ovarian cancer	0.000192	0.000901	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—ovarian cancer	0.000192	0.000896	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—ovarian cancer	0.00019	0.000888	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—ovarian cancer	0.00019	0.000888	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—ovarian cancer	0.000188	0.000879	CcSEcCtD
Amitriptyline—Vomiting—Docetaxel—ovarian cancer	0.000188	0.000878	CcSEcCtD
Amitriptyline—Rash—Docetaxel—ovarian cancer	0.000186	0.000871	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—ovarian cancer	0.000186	0.00087	CcSEcCtD
Amitriptyline—Dermatitis—Docetaxel—ovarian cancer	0.000186	0.00087	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—ovarian cancer	0.000186	0.000869	CcSEcCtD
Amitriptyline—Headache—Docetaxel—ovarian cancer	0.000185	0.000865	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—ovarian cancer	0.000184	0.000862	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—ovarian cancer	0.000181	0.000848	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00018	0.000844	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—ovarian cancer	0.00018	0.000843	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—ovarian cancer	0.00018	0.000841	CcSEcCtD
Amitriptyline—Paraesthesia—Epirubicin—ovarian cancer	0.000179	0.000836	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000178	0.000833	CcSEcCtD
Amitriptyline—Somnolence—Epirubicin—ovarian cancer	0.000177	0.000828	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—ovarian cancer	0.000176	0.000822	CcSEcCtD
Amitriptyline—Nausea—Docetaxel—ovarian cancer	0.000175	0.00082	CcSEcCtD
Amitriptyline—Dyspepsia—Epirubicin—ovarian cancer	0.000175	0.00082	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—ovarian cancer	0.000173	0.00081	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—ovarian cancer	0.000172	0.000805	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—ovarian cancer	0.000172	0.000803	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—ovarian cancer	0.00017	0.000797	CcSEcCtD
Amitriptyline—ABCB1—lymph node—ovarian cancer	0.000169	0.00121	CbGeAlD
Amitriptyline—Insomnia—Doxorubicin—ovarian cancer	0.000167	0.00078	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—ovarian cancer	0.000165	0.000774	CcSEcCtD
Amitriptyline—Feeling abnormal—Epirubicin—ovarian cancer	0.000164	0.000768	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—ovarian cancer	0.000164	0.000766	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—ovarian cancer	0.000162	0.000759	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—ovarian cancer	0.00016	0.000749	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—ovarian cancer	0.000159	0.000743	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—ovarian cancer	0.000158	0.00074	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—ovarian cancer	0.000158	0.000737	CcSEcCtD
Amitriptyline—Body temperature increased—Epirubicin—ovarian cancer	0.000157	0.000736	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—ovarian cancer	0.000152	0.00071	CcSEcCtD
Amitriptyline—Urticaria—Doxorubicin—ovarian cancer	0.000146	0.000685	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—ovarian cancer	0.000146	0.000681	CcSEcCtD
Amitriptyline—Asthenia—Epirubicin—ovarian cancer	0.000143	0.000668	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—ovarian cancer	0.000141	0.000659	CcSEcCtD
Amitriptyline—Diarrhoea—Epirubicin—ovarian cancer	0.000136	0.000637	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—ovarian cancer	0.000132	0.000618	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—ovarian cancer	0.000132	0.000616	CcSEcCtD
Amitriptyline—Pruritus—Doxorubicin—ovarian cancer	0.00013	0.00061	CcSEcCtD
Amitriptyline—Vomiting—Epirubicin—ovarian cancer	0.000127	0.000592	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—ovarian cancer	0.000126	0.00059	CcSEcCtD
Amitriptyline—Rash—Epirubicin—ovarian cancer	0.000126	0.000587	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—ovarian cancer	0.000125	0.000587	CcSEcCtD
Amitriptyline—Headache—Epirubicin—ovarian cancer	0.000125	0.000584	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—ovarian cancer	0.000122	0.00057	CcSEcCtD
Amitriptyline—Nausea—Epirubicin—ovarian cancer	0.000118	0.000553	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—ovarian cancer	0.000117	0.000548	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—ovarian cancer	0.000116	0.000543	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—ovarian cancer	0.000116	0.000543	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—ovarian cancer	0.000115	0.00054	CcSEcCtD
Amitriptyline—Nausea—Doxorubicin—ovarian cancer	0.000109	0.000512	CcSEcCtD
Amitriptyline—Epinastine—ABCB1—ovarian cancer	1.31e-05	0.235	CrCbGaD
Amitriptyline—Clomipramine—ABCB1—ovarian cancer	6.91e-06	0.124	CrCbGaD
Amitriptyline—Chlorprothixene—ABCB1—ovarian cancer	6.88e-06	0.124	CrCbGaD
Amitriptyline—Trimipramine—ABCB1—ovarian cancer	6.36e-06	0.114	CrCbGaD
Amitriptyline—Promethazine—ABCB1—ovarian cancer	6.12e-06	0.11	CrCbGaD
Amitriptyline—Doxepin—ABCB1—ovarian cancer	6.06e-06	0.109	CrCbGaD
Amitriptyline—Desipramine—ABCB1—ovarian cancer	5.56e-06	0.0999	CrCbGaD
Amitriptyline—ABCB1—Metabolism—PIK3CD—ovarian cancer	5.19e-06	3.05e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PTEN—ovarian cancer	5.19e-06	3.05e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MMP9—ovarian cancer	5.18e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTEN—ovarian cancer	5.18e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—PIK3CA—ovarian cancer	5.18e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CAV1—ovarian cancer	5.17e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—ovarian cancer	5.17e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PTEN—ovarian cancer	5.17e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CB—ovarian cancer	5.16e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—HRAS—ovarian cancer	5.15e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—AKT1—ovarian cancer	5.15e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PTEN—ovarian cancer	5.15e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IL6—ovarian cancer	5.15e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MAPK3—ovarian cancer	5.14e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	5.13e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MMP9—ovarian cancer	5.13e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—STAT3—ovarian cancer	5.12e-06	3.01e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	5.12e-06	3.01e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	5.11e-06	3e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	5.11e-06	3e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTEN—ovarian cancer	5.1e-06	3e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	5.09e-06	2.99e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	5.08e-06	2.98e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—ovarian cancer	5.08e-06	2.98e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—ovarian cancer	5.07e-06	2.98e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	5.07e-06	2.98e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—ovarian cancer	5.06e-06	2.97e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.05e-06	2.97e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	5.04e-06	2.96e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—ovarian cancer	5.04e-06	2.96e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	5.03e-06	2.96e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—ovarian cancer	5.03e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—ovarian cancer	5.02e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—ovarian cancer	5.01e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HRAS—ovarian cancer	5e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	5e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—ovarian cancer	5e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	4.98e-06	2.92e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—ovarian cancer	4.97e-06	2.92e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	4.96e-06	2.92e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TYMS—ovarian cancer	4.96e-06	2.91e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.94e-06	2.9e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—ovarian cancer	4.93e-06	2.9e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—ovarian cancer	4.92e-06	2.89e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	4.9e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	4.89e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CD—ovarian cancer	4.89e-06	2.87e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MAPK1—ovarian cancer	4.89e-06	2.87e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—ovarian cancer	4.89e-06	2.87e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—ovarian cancer	4.87e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—ovarian cancer	4.87e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	4.86e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—ovarian cancer	4.86e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	4.85e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.85e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HRAS—ovarian cancer	4.79e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—ovarian cancer	4.79e-06	2.81e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—ovarian cancer	4.77e-06	2.8e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—ovarian cancer	4.76e-06	2.8e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—ovarian cancer	4.76e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	4.76e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—ovarian cancer	4.75e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	4.73e-06	2.78e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STAT3—ovarian cancer	4.72e-06	2.78e-05	CbGpPWpGaD
Amitriptyline—Imipramine—ABCB1—ovarian cancer	4.72e-06	0.0847	CrCbGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.71e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NRAS—ovarian cancer	4.71e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—ovarian cancer	4.71e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—ovarian cancer	4.71e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	4.69e-06	2.76e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—ovarian cancer	4.68e-06	2.75e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—ovarian cancer	4.68e-06	2.75e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—ovarian cancer	4.68e-06	2.75e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	4.67e-06	2.74e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	4.66e-06	2.74e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	4.66e-06	2.74e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—ovarian cancer	4.65e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—ovarian cancer	4.65e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STAT3—ovarian cancer	4.65e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STAT3—ovarian cancer	4.64e-06	2.72e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NRAS—ovarian cancer	4.64e-06	2.72e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.64e-06	2.72e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NRAS—ovarian cancer	4.63e-06	2.72e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STAT3—ovarian cancer	4.62e-06	2.72e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—ovarian cancer	4.62e-06	2.71e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	4.61e-06	2.71e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NRAS—ovarian cancer	4.61e-06	2.71e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	4.61e-06	2.71e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STAT3—ovarian cancer	4.61e-06	2.71e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NRAS—ovarian cancer	4.6e-06	2.7e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	4.6e-06	2.7e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—ovarian cancer	4.59e-06	2.7e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—ovarian cancer	4.59e-06	2.69e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STAT3—ovarian cancer	4.56e-06	2.68e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NRAS—ovarian cancer	4.55e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—ovarian cancer	4.55e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	4.55e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HRAS—ovarian cancer	4.55e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	4.54e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.52e-06	2.66e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK3—ovarian cancer	4.51e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HRAS—ovarian cancer	4.5e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HRAS—ovarian cancer	4.5e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTEN—ovarian cancer	4.49e-06	2.64e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTEN—ovarian cancer	4.46e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	4.44e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK3—ovarian cancer	4.43e-06	2.6e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—ovarian cancer	4.42e-06	2.6e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	4.42e-06	2.59e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	4.4e-06	2.59e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	4.4e-06	2.58e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—ovarian cancer	4.39e-06	2.58e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	4.36e-06	2.56e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—ovarian cancer	4.35e-06	2.56e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	4.35e-06	2.55e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—ovarian cancer	4.35e-06	2.55e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—ovarian cancer	4.32e-06	2.54e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—ovarian cancer	4.31e-06	2.53e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—ovarian cancer	4.31e-06	2.53e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—ovarian cancer	4.31e-06	2.53e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—ovarian cancer	4.3e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK1—ovarian cancer	4.29e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—ovarian cancer	4.29e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—ovarian cancer	4.28e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	4.27e-06	2.51e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.26e-06	2.5e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	4.24e-06	2.49e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—ovarian cancer	4.24e-06	2.49e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—ovarian cancer	4.23e-06	2.49e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—ovarian cancer	4.23e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	4.23e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CB—ovarian cancer	4.23e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	4.22e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—ovarian cancer	4.22e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	4.22e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	4.22e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK1—ovarian cancer	4.22e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—ovarian cancer	4.21e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	4.2e-06	2.47e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—ovarian cancer	4.2e-06	2.47e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	4.19e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—ovarian cancer	4.19e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	4.15e-06	2.44e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—ovarian cancer	4.15e-06	2.44e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.14e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	4.14e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	4.14e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—ovarian cancer	4.11e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—ovarian cancer	4.08e-06	2.4e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—ovarian cancer	4.06e-06	2.38e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	4.04e-06	2.37e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	4.04e-06	2.37e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—ovarian cancer	4.02e-06	2.36e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTEN—ovarian cancer	4.01e-06	2.35e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CAV1—ovarian cancer	3.99e-06	2.35e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—ovarian cancer	3.99e-06	2.34e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—ovarian cancer	3.99e-06	2.34e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—ovarian cancer	3.98e-06	2.34e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—ovarian cancer	3.98e-06	2.34e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—ovarian cancer	3.98e-06	2.34e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—ovarian cancer	3.97e-06	2.33e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—ovarian cancer	3.96e-06	2.32e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—ovarian cancer	3.93e-06	2.31e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HRAS—ovarian cancer	3.93e-06	2.31e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—ovarian cancer	3.92e-06	2.3e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTEN—ovarian cancer	3.91e-06	2.3e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—ovarian cancer	3.91e-06	2.3e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	3.91e-06	2.3e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HRAS—ovarian cancer	3.91e-06	2.29e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	3.84e-06	2.26e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	3.84e-06	2.26e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—ovarian cancer	3.76e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—ovarian cancer	3.74e-06	2.2e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	3.74e-06	2.2e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—ovarian cancer	3.74e-06	2.2e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	3.73e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTEN—ovarian cancer	3.68e-06	2.16e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	3.67e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.66e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	3.66e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.66e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTEN—ovarian cancer	3.65e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	3.65e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.64e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	3.63e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	3.63e-06	2.13e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.61e-06	2.12e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—ovarian cancer	3.6e-06	2.12e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	3.6e-06	2.11e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	3.59e-06	2.11e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—ovarian cancer	3.58e-06	2.1e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—ovarian cancer	3.55e-06	2.09e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—ovarian cancer	3.55e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—ovarian cancer	3.54e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—ovarian cancer	3.53e-06	2.07e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—ovarian cancer	3.52e-06	2.07e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—ovarian cancer	3.48e-06	2.05e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—ovarian cancer	3.47e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—ovarian cancer	3.47e-06	2.04e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—ovarian cancer	3.45e-06	2.03e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HRAS—ovarian cancer	3.45e-06	2.03e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRAS—ovarian cancer	3.39e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRAS—ovarian cancer	3.38e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRAS—ovarian cancer	3.37e-06	1.98e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRAS—ovarian cancer	3.36e-06	1.98e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	3.34e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRAS—ovarian cancer	3.33e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	3.32e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	3.3e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—ovarian cancer	3.3e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—ovarian cancer	3.26e-06	1.91e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—ovarian cancer	3.25e-06	1.91e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—ovarian cancer	3.24e-06	1.9e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—ovarian cancer	3.23e-06	1.9e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—ovarian cancer	3.23e-06	1.9e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—ovarian cancer	3.22e-06	1.89e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.2e-06	1.88e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—ovarian cancer	3.19e-06	1.87e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—ovarian cancer	3.18e-06	1.87e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—ovarian cancer	3.17e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—ovarian cancer	3.15e-06	1.85e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTEN—ovarian cancer	3.12e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	3.09e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—ovarian cancer	3.05e-06	1.79e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—ovarian cancer	3.04e-06	1.79e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—ovarian cancer	2.99e-06	1.76e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—ovarian cancer	2.99e-06	1.76e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—ovarian cancer	2.99e-06	1.76e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—ovarian cancer	2.99e-06	1.75e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—ovarian cancer	2.98e-06	1.75e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—ovarian cancer	2.97e-06	1.74e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—ovarian cancer	2.95e-06	1.74e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—ovarian cancer	2.94e-06	1.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	2.93e-06	1.72e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.83e-06	1.66e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.79e-06	1.64e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.76e-06	1.62e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	2.72e-06	1.6e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.6e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—ovarian cancer	2.59e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.58e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—ovarian cancer	2.57e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTEN—ovarian cancer	2.41e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—ovarian cancer	2.31e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—ovarian cancer	2.25e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.2e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—ovarian cancer	2.12e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—ovarian cancer	2.1e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—ovarian cancer	1.8e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.7e-06	9.98e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—ovarian cancer	1.39e-06	8.16e-06	CbGpPWpGaD
